These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23457630)

  • 1. TRIF is required for TLR4 mediated adjuvant effects on T cell clonal expansion.
    Gandhapudi SK; Chilton PM; Mitchell TC
    PLoS One; 2013; 8(2):e56855. PubMed ID: 23457630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant.
    Orr MT; Duthie MS; Windish HP; Lucas EA; Guderian JA; Hudson TE; Shaverdian N; O'Donnell J; Desbien AL; Reed SG; Coler RN
    Eur J Immunol; 2013 Sep; 43(9):2398-408. PubMed ID: 23716300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responses.
    Xiao L; Kim J; Lim M; Dai B; Yang L; Reed SG; Baltimore D; Wang P
    Vaccine; 2012 Mar; 30(15):2570-81. PubMed ID: 22314134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface immunogenic protein from Streptococcus agalactiae and
    Díaz-Dinamarca DA; Salazar ML; Escobar DF; Castillo BN; Valdebenito B; Díaz P; Manubens A; Salazar F; Troncoso MF; Lavandero S; Díaz J; Becker MI; Vásquez AE
    Front Immunol; 2023; 14():1186188. PubMed ID: 37790926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of impaired NLRP3 inflammasome priming by monophosphoryl lipid A.
    Embry CA; Franchi L; Nuñez G; Mitchell TC
    Sci Signal; 2011 May; 4(171):ra28. PubMed ID: 21540455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF.
    Kolb JP; Casella CR; SenGupta S; Chilton PM; Mitchell TC
    Sci Signal; 2014 Nov; 7(351):ra108. PubMed ID: 25389373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.
    Mata-Haro V; Cekic C; Martin M; Chilton PM; Casella CR; Mitchell TC
    Science; 2007 Jun; 316(5831):1628-32. PubMed ID: 17569868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
    Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
    Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recruitment of TLR adapter TRIF to TLR4 signaling complex is mediated by the second helical region of TRIF TIR domain.
    Piao W; Ru LW; Piepenbrink KH; Sundberg EJ; Vogel SN; Toshchakov VY
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19036-41. PubMed ID: 24194546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential outcome of TRIF-mediated signaling in TLR4 and TLR3 induced DC maturation.
    Hu W; Jain A; Gao Y; Dozmorov IM; Mandraju R; Wakeland EK; Pasare C
    Proc Natl Acad Sci U S A; 2015 Nov; 112(45):13994-9. PubMed ID: 26508631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Th1/Tfh-like biased responses elicited by the rASP-1 innate adjuvant are dependent on TRIF and Type I IFN receptor pathways.
    George PJ; Marches R; Nehar-Belaid D; Banchereau J; Lustigman S
    Front Immunol; 2022; 13():961094. PubMed ID: 36119026
    [No Abstract]   [Full Text] [Related]  

  • 12. The TLR4-TRIF pathway can protect against the development of experimental allergic asthma.
    Shalaby KH; Al Heialy S; Tsuchiya K; Farahnak S; McGovern TK; Risse PA; Suh WK; Qureshi ST; Martin JG
    Immunology; 2017 Sep; 152(1):138-149. PubMed ID: 28502093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Campylobacter jejuni-induced activation of dendritic cells involves cooperative signaling through Toll-like receptor 4 (TLR4)-MyD88 and TLR4-TRIF axes.
    Rathinam VA; Appledorn DM; Hoag KA; Amalfitano A; Mansfield LS
    Infect Immun; 2009 Jun; 77(6):2499-507. PubMed ID: 19332531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages.
    Ruckdeschel K; Pfaffinger G; Haase R; Sing A; Weighardt H; Häcker G; Holzmann B; Heesemann J
    J Immunol; 2004 Sep; 173(5):3320-8. PubMed ID: 15322195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
    Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant role of the MyD88-dependent signaling pathway in mediating early endotoxin-induced murine ileus.
    Buchholz BM; Billiar TR; Bauer AJ
    Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G531-8. PubMed ID: 20508155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR4 and Toll-IL-1 receptor domain-containing adapter-inducing IFN-beta, but not MyD88, regulate Escherichia coli-induced dendritic cell maturation and apoptosis in vivo.
    De Trez C; Pajak B; Brait M; Glaichenhaus N; Urbain J; Moser M; Lauvau G; Muraille E
    J Immunol; 2005 Jul; 175(2):839-46. PubMed ID: 16002681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist.
    Bowen WS; Minns LA; Johnson DA; Mitchell TC; Hutton MM; Evans JT
    Sci Signal; 2012 Feb; 5(211):ra13. PubMed ID: 22337809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR4 agonist activity of Alcaligenes lipid a utilizes MyD88 and TRIF signaling pathways for efficient antigen presentation and T cell differentiation by dendritic cells.
    Sun X; Hosomi K; Shimoyama A; Yoshii K; Lan H; Wang Y; Yamaura H; Nagatake T; Ishii KJ; Akira S; Kiyono H; Fukase K; Kunisawa J
    Int Immunopharmacol; 2023 Apr; 117():109852. PubMed ID: 36806039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation.
    Shen H; Tesar BM; Walker WE; Goldstein DR
    J Immunol; 2008 Aug; 181(3):1849-58. PubMed ID: 18641322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.